0001209191-22-047428.txt : 20220824 0001209191-22-047428.hdr.sgml : 20220824 20220824210055 ACCESSION NUMBER: 0001209191-22-047428 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220824 DATE AS OF CHANGE: 20220824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galindo Alejandro CENTRAL INDEX KEY: 0001821447 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50865 FILM NUMBER: 221192768 MAIL ADDRESS: STREET 1: 30930 RUSSELL RANCH RD STREET 2: STE 300 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANNKIND CORP CENTRAL INDEX KEY: 0000899460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133607736 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 818-661-5000 MAIL ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-02-28 2022-02-28 0 0000899460 MANNKIND CORP MNKD 0001821447 Galindo Alejandro 1 CASPER STREET DANBURY CT 06810 0 1 0 0 EVP Endocrine Business Unit Common Stock,$.01 par value 2022-02-28 4 A 0 36900 2.71 A 576690 D This Form 4 is being amended to correct the transaction code. The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective February 28, 2022. The purchase was approved by the Company's Board of Directors. /s/ Alejandro Galindo 2022-08-24